HRMY Annual CFO
$219.39 M
+$74.92 M+51.86%
31 December 2023
Summary:
As of January 23, 2025, HRMY annual cash flow from operations is $219.39 million, with the most recent change of +$74.92 million (+51.86%) on December 31, 2023. During the last 3 years, it has risen by +$222.37 million (+7449.65%). HRMY annual CFO is now at all-time high.HRMY Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HRMY Quarterly CFO
$70.50 M
+$27.88 M+65.43%
30 September 2024
Summary:
As of January 23, 2025, HRMY quarterly cash flow from operations is $70.50 million, with the most recent change of +$27.88 million (+65.43%) on September 30, 2024. Over the past year, it has dropped by -$6.16 million (-8.04%). HRMY quarterly CFO is now -8.04% below its all-time high of $76.67 million, reached on December 31, 2023.HRMY Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HRMY TTM CFO
$220.92 M
+$7.40 M+3.47%
30 September 2024
Summary:
As of January 23, 2025, HRMY TTM cash flow from operations is $220.92 million, with the most recent change of +$7.40 million (+3.47%) on September 30, 2024. Over the past year, it has increased by +$1.54 million (+0.70%). HRMY TTM CFO is now at all-time high.HRMY TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HRMY Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +51.9% | -8.0% | +0.7% |
| 3 y3 years | +7449.6% | +131.7% | +210.8% |
| 5 y5 years | +665.4% | +400.6% | +392.9% |
HRMY Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +122.6% | -8.0% | +164.3% | at high | +124.2% |
| 5 y | 5-year | at high | +390.8% | -8.0% | +364.0% | at high | +341.3% |
| alltime | all time | at high | +390.8% | -8.0% | +364.0% | at high | +341.3% |
Harmony Biosciences Holdings Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $70.50 M(+65.4%) | $220.92 M(+3.5%) |
| June 2024 | - | $42.62 M(+36.9%) | $213.52 M(+2.7%) |
| Mar 2024 | - | $31.14 M(-59.4%) | $207.97 M(-5.2%) |
| Dec 2023 | $219.39 M(+51.9%) | $76.67 M(+21.5%) | $219.39 M(+29.5%) |
| Sept 2023 | - | $63.10 M(+70.3%) | $169.40 M(+4.9%) |
| June 2023 | - | $37.06 M(-12.9%) | $161.50 M(+2.1%) |
| Mar 2023 | - | $42.56 M(+59.5%) | $158.17 M(+9.5%) |
| Dec 2022 | $144.47 M(+46.6%) | $26.68 M(-51.7%) | $144.47 M(-7.0%) |
| Sept 2022 | - | $55.20 M(+63.7%) | $155.32 M(+19.0%) |
| June 2022 | - | $33.73 M(+16.9%) | $130.54 M(+13.6%) |
| Mar 2022 | - | $28.85 M(-23.1%) | $114.88 M(+16.6%) |
| Dec 2021 | $98.56 M | $37.53 M(+23.4%) | $98.56 M(+38.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | $30.42 M(+68.4%) | $71.07 M(+43.6%) |
| June 2021 | - | $18.07 M(+44.2%) | $49.48 M(+36.5%) |
| Mar 2021 | - | $12.53 M(+24.7%) | $36.25 M(-1314.3%) |
| Dec 2020 | -$2.98 M(-96.0%) | $10.05 M(+13.7%) | -$2.98 M(-91.9%) |
| Sept 2020 | - | $8.84 M(+82.9%) | -$37.02 M(-46.6%) |
| June 2020 | - | $4.83 M(-118.1%) | -$69.31 M(-24.3%) |
| Mar 2020 | - | -$26.70 M(+11.3%) | -$91.54 M(+21.4%) |
| Dec 2019 | -$75.44 M(+94.4%) | -$23.99 M(+2.3%) | -$75.44 M(+46.6%) |
| Sept 2019 | - | -$23.45 M(+34.8%) | -$51.45 M(+83.8%) |
| June 2019 | - | -$17.40 M(+64.2%) | -$28.00 M(+164.2%) |
| Mar 2019 | - | -$10.60 M | -$10.60 M |
| Dec 2018 | -$38.80 M | - | - |
FAQ
- What is Harmony Biosciences Holdings annual cash flow from operations?
- What is the all time high annual CFO for Harmony Biosciences Holdings?
- What is Harmony Biosciences Holdings annual CFO year-on-year change?
- What is Harmony Biosciences Holdings quarterly cash flow from operations?
- What is the all time high quarterly CFO for Harmony Biosciences Holdings?
- What is Harmony Biosciences Holdings quarterly CFO year-on-year change?
- What is Harmony Biosciences Holdings TTM cash flow from operations?
- What is the all time high TTM CFO for Harmony Biosciences Holdings?
- What is Harmony Biosciences Holdings TTM CFO year-on-year change?
What is Harmony Biosciences Holdings annual cash flow from operations?
The current annual CFO of HRMY is $219.39 M
What is the all time high annual CFO for Harmony Biosciences Holdings?
Harmony Biosciences Holdings all-time high annual cash flow from operations is $219.39 M
What is Harmony Biosciences Holdings annual CFO year-on-year change?
Over the past year, HRMY annual cash flow from operations has changed by +$74.92 M (+51.86%)
What is Harmony Biosciences Holdings quarterly cash flow from operations?
The current quarterly CFO of HRMY is $70.50 M
What is the all time high quarterly CFO for Harmony Biosciences Holdings?
Harmony Biosciences Holdings all-time high quarterly cash flow from operations is $76.67 M
What is Harmony Biosciences Holdings quarterly CFO year-on-year change?
Over the past year, HRMY quarterly cash flow from operations has changed by -$6.16 M (-8.04%)
What is Harmony Biosciences Holdings TTM cash flow from operations?
The current TTM CFO of HRMY is $220.92 M
What is the all time high TTM CFO for Harmony Biosciences Holdings?
Harmony Biosciences Holdings all-time high TTM cash flow from operations is $220.92 M
What is Harmony Biosciences Holdings TTM CFO year-on-year change?
Over the past year, HRMY TTM cash flow from operations has changed by +$1.54 M (+0.70%)